However, despite the fact that FOXG1 syndrome patients might not benefit immediately from insights coming from basic research, understanding the molecular etiology of FOXG1 syndrome might identify novel therapeutic targets and new resources of drugs aiming to alleviate some symptoms of the patients. The gene discussed is FOXG1; the disease is Down syndrome.